NATCO Pharma Wins Landmark Legal Battle to Launch Affordable Risdiplam for Spinal Muscular Atrophy in India
NATCO Pharma Limited has announced a significant legal victory in its ongoing patent dispute with Roche, enabling the company to launch its generic version of Risdiplam, a drug used in the treatment of Spinal Muscular Atrophy (SMA), in India.










